CME Group Inc. $CME Shares Acquired by Lockheed Martin Investment Management Co.

Lockheed Martin Investment Management Co. boosted its position in CME Group Inc. (NASDAQ:CME) by 12.0% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 59,330 shares of the financial services provider’s stock after acquiring an additional 6,340 shares during the quarter. Lockheed Martin Investment Management Co.’s holdings in CME Group were worth $16,202,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Northwestern Mutual Investment Management Company LLC lifted its holdings in CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after buying an additional 37 shares in the last quarter. Wakefield Asset Management LLLP lifted its holdings in CME Group by 4.8% in the 4th quarter. Wakefield Asset Management LLLP now owns 1,654 shares of the financial services provider’s stock worth $452,000 after buying an additional 76 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in CME Group by 1,777.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 241,023 shares of the financial services provider’s stock worth $65,819,000 after buying an additional 228,187 shares in the last quarter. PAX Financial Group LLC lifted its holdings in CME Group by 11.0% in the 4th quarter. PAX Financial Group LLC now owns 1,548 shares of the financial services provider’s stock worth $423,000 after buying an additional 153 shares in the last quarter. Finally, Phoenix Financial Ltd. lifted its holdings in CME Group by 7.6% in the 4th quarter. Phoenix Financial Ltd. now owns 8,470 shares of the financial services provider’s stock worth $2,312,000 after buying an additional 600 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Price Performance

CME opened at $298.86 on Friday. The company has a 50-day moving average of $298.07 and a 200-day moving average of $288.06. The company has a market capitalization of $108.29 billion, a P/E ratio of 25.50, a PEG ratio of 3.60 and a beta of 0.23. CME Group Inc. has a 1-year low of $257.17 and a 1-year high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company’s revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.80 EPS. Equities analysts expect that CME Group Inc. will post 12.26 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be given a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. CME Group’s payout ratio is presently 44.37%.

Insider Transactions at CME Group

In other news, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $305.90, for a total value of $91,770.00. Following the completion of the sale, the director owned 24,999 shares of the company’s stock, valued at approximately $7,647,194.10. The trade was a 1.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the sale, the general counsel directly owned 7,192 shares of the company’s stock, valued at approximately $2,397,597.04. This represents a 31.39% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 7,791 shares of company stock valued at $2,489,421. Insiders own 0.30% of the company’s stock.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group announced plans to launch Nasdaq CME Crypto Index futures on June 8, pending regulatory review. The new contract would be CME’s first-ever market-cap weighted futures product and expands its regulated crypto offerings, which investors may view as a growth driver. Article: CME Group to Launch Nasdaq CME Crypto Index Futures
• Positive Sentiment: Reports that Interactive Brokers is integrating CME event contracts into a unified prediction-markets platform highlight CME’s growing relevance in new trading products and could support longer-term volume opportunities. Article: Interactive Brokers Debuts All-in-One Prediction Market Portal
• Positive Sentiment: Coverage of CME’s annual meeting preliminary results was routine governance news, but it showed no apparent disruption to the company’s leadership or shareholder base. Article: CME Group Inc. Announces Preliminary Results of 2026 Annual Meeting
• Neutral Sentiment: Multiple reports said CME and Intercontinental Exchange are lobbying U.S. regulators to increase scrutiny of Hyperliquid, arguing that the unregulated platform could affect price discovery in oil and crypto markets. This is more about competitive/regulatory positioning than a direct business event for CME, but it may be seen as CME defending the regulated futures ecosystem. Article: CME, ICE Push US to Curb Crypto’s Offshore Oil Trading Upstart
• Neutral Sentiment: Broader market commentary referenced CME’s FedWatch tool showing higher odds of a Fed hike later in 2026, but this is an indirect macro signal rather than company-specific news. Article: The Bond Market Just Fired A Warning Shot At The AI Rally — Fed Hike Ahead

Analyst Upgrades and Downgrades

A number of equities analysts have commented on CME shares. TD Cowen cut their price objective on shares of CME Group from $340.00 to $323.00 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Piper Sandler boosted their price objective on shares of CME Group from $313.00 to $329.00 and gave the stock an “overweight” rating in a report on Wednesday, April 15th. Keefe, Bruyette & Woods started coverage on shares of CME Group in a report on Wednesday, April 8th. They issued a “market perform” rating and a $305.00 price objective on the stock. Raymond James Financial boosted their price objective on shares of CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a report on Monday, April 6th. Finally, Royal Bank Of Canada boosted their price objective on shares of CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a report on Thursday, February 5th. Two analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $305.29.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.